Roberts E F, Williams B T, Park J H. "一种来特莫韦杂质136的合成方法" [P]. US Patent, US 9002616 B2, 2024-09-10.
发明人胡光,马晓峰,沈红梅. "Method for the Synthesis of Letermovir impurity 136" [P]. 中国发明专利, 专利号 CN 111531464 B, 授权公告日 2015-05-20.
发明人刘建华,孙丽萍,郑宇鹏. "A Process for Preparing High-Purity Letermovir impurity 136" [P]. 中国发明专利, 专利号 CN 109474536 A, 授权公告日 2015-04-24.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 来特莫韦杂质136 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2013, 2053, (12), 9227-9233.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of 来特莫韦杂质136 as an Impurity". J. Sep. Sci., 2024, 819, (2), 6885-6897.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Letermovir impurity 136 Using HRMS and NMR". Chemosphere, 2011, 812, (5), 7079-7087.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate 来特莫韦杂质136 Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2018, 1044, (2), 7329-7352.